Kevin C. Gorman

2020

In 2020, Kevin C. Gorman earned a total compensation of $13.9M as Chief Executive Officer at Neurocrine Biosciences, a 47% increase compared to previous year.

Compensation breakdown

Bonus$542,500
Option Awards$7,124,633
Salary$775,000
Stock Awards$5,375,188
Other$63,311
Total$13,880,632

Gorman received $7.1M in option awards, accounting for 51% of the total pay in 2020.

Gorman also received $542.5K in bonus, $775K in salary, $5.4M in stock awards and $63.3K in other compensation.

Rankings

In 2020, Kevin C. Gorman's compensation ranked 477th out of 13,090 executives tracked by ExecPay. In other words, Gorman earned more than 96.4% of executives.

ClassificationRankingPercentile
All
477
out of 13,090
96th
Division
Manufacturing
161
out of 5,618
97th
Major group
Chemicals And Allied Products
56
out of 2,251
98th
Industry group
Drugs
50
out of 1,951
97th
Industry
Biological Products, Except Diagnostic Substances
15
out of 411
96th

Pay ratio

Kevin C. Gorman's Pay$13,880,632
Median Employee's Pay$241,848
Pay Ratio

57

to 1

In 2020, the annual total compensation of Kevin C. Gorman was $13,880,632.

The annual total compensation of the median employee at Neurocrine Biosciences was $241,848.

The ratio of Kevin C. Gorman's pay to the pay of median employee was therefore 57 to one.

Source: SEC filing on April 9, 2021.

Gorman's colleagues

We found four more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2020.

2020

Kyle Gano

Neurocrine Biosciences

Chief Development and Strategy Officer

2020

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2020

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2020

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

News

In-depth

You may also like